These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 28494457)
1. Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1. Yu L; Tu Y; Jia X; Fang K; Liu L; Wan L; Xiang C; Wang Y; Sun X; Liu T; Yu D; Cao W; Song Y; Fan Y Cell Physiol Biochem; 2017; 42(1):55-67. PubMed ID: 28494457 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle. Paffett ML; Lucas SN; Campen MJ Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233 [TBL] [Abstract][Full Text] [Related]
3. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target. Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330 [TBL] [Abstract][Full Text] [Related]
4. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats. He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231 [TBL] [Abstract][Full Text] [Related]
5. Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension. Zurlo G; Piquereau J; Moulin M; Pires Da Silva J; Gressette M; Ranchoux B; Garnier A; Ventura-Clapier R; Fadel E; Humbert M; Lemaire C; Perros F; Veksler V J Hypertens; 2018 May; 36(5):1164-1177. PubMed ID: 29369849 [TBL] [Abstract][Full Text] [Related]
6. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454 [TBL] [Abstract][Full Text] [Related]
7. Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension. Zhou S; Li MT; Jia YY; Liu JJ; Wang Q; Tian Z; Liu YT; Chen HZ; Liu DP; Zeng XF Biomed Res Int; 2015; 2015():762349. PubMed ID: 26273643 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation. Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628 [TBL] [Abstract][Full Text] [Related]
9. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1. Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway. Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575 [TBL] [Abstract][Full Text] [Related]
11. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway. He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the Effect of Circ-Sirt1 on the Expression of SIRT1 and Its Role in Pathology of Pulmonary Hypertension. Diao W; Liu G; Shi C; Jiang Y; Li H; Meng J; Shi Y; Chang M; Liu X Cell Transplant; 2022; 31():9636897221081479. PubMed ID: 35225027 [TBL] [Abstract][Full Text] [Related]
13. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Cheng G; Wang X; Li Y; He L Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784 [TBL] [Abstract][Full Text] [Related]
14. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation. Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770 [TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway. Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156 [TBL] [Abstract][Full Text] [Related]
17. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation. Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355 [TBL] [Abstract][Full Text] [Related]
18. STARS knockout attenuates hypoxia-induced pulmonary arterial hypertension by suppressing pulmonary arterial smooth muscle cell proliferation. Shi Z; Wu H; Luo J; Sun X Biomed Pharmacother; 2017 Mar; 87():397-404. PubMed ID: 28068629 [TBL] [Abstract][Full Text] [Related]